A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination

Tan, Lii Jye; Koh, Cai Ping; Lai, Shau-Kong; Poh, Wong Cheng; Othman, Mohammad; Hussin, Huzlinda

doi:10.1016/j.forsciint.2022.111469

Cited by 2 publications

(3 citation statements)

References 126 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The release of proinflammatory cytokines (IL-1, IL-6, IL-8, TNF-a), T-cell depletion, and activation of oncogenic pathways (JAK-STAT, MAPK, NF-kB) caused by COVID-19 infections may pose a risk of tumorigenesis [2][3][4] . COVID-19 vaccinations have been associated with multisystem inflammatory syndrome (MIS-V), allergy, thrombotic thrombocytopenia, and myocarditis 5,6 . Although there is currently no conclusive evidence linking COVID-19 vaccines to tumor growth, a small percentage (3.9%) of 733 patients participating in a BNT162b2 mRNA vaccine trial (NCT04368728) did have tumor activation 7 .…”

Section: Discussionmentioning

confidence: 99%

Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine

Yilmaz,

Goker,

Gedikoglu

et al. 2024

JBJS Case Connector

View full text Add to dashboard Cite

Case: In this report, a rare case of primary cutaneous adenoid cystic carcinoma (PCACC) localized in the subcutaneous tissue of the scapular region that grew after BNT162b2 corona virus disease of 2019 (COVID-19) vaccination is presented and may be explained by CD4 and CD8 cell infiltration. The BNT162b2 mRNA vaccine has been associated with a multisystem inflammatory syndrome (MIS-V). A comparable immune reaction could potentially enhance tumor growth rate. Conclusion: Primary cutaneous adenoid cystic carcinomas are rare tumors with unique locations. Further studies with case series are required to establish management algorithms for PCACC and investigate the potential effect of vaccination.

show abstract

Section: Discussionmentioning

confidence: 99%

Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine

Yilmaz,

Goker,

Gedikoglu

et al. 2024

JBJS Case Connector

View full text Add to dashboard Cite

show abstract

“…Vaccine-related injuries or death should be thoroughly investigated and evaluated nationally, and plans for such a goal should be established and prepared before the new infectious disease pandemic begins. 42 …”

Section: Analysis and Preparations Of Possible Vaccine Adverse Effect...mentioning

confidence: 99%

“…Several studies have reported the incidence of anaphylaxis, myocarditis, and vaccine-induced immune thrombotic thrombocytopenia. 17 42 43 As the adverse effects identified in clinical studies before marketing approval do not represent all adverse effects of the vaccine, it is necessary to identify the vaccine side effects through continuous investigation and research activities and inform the public of new related issues and data.…”

Section: Analysis and Preparations Of Possible Vaccine Adverse Effect...mentioning

confidence: 99%

Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19

Wie,

Jung,

Kim

2023

J Korean Med Sci

View full text Add to dashboard Cite

Social isolation and control owing to coronavirus disease 2019 (COVID-19) are easing; however, concerns regarding new infectious diseases have not disappeared. Given epidemic experiences such as severe acute respiratory syndrome (SARS), the influenza pandemic, Middle East respiratory syndrome (MERS), and COVID-19, it is necessary to prepare for the outbreak of new infectious diseases and situations in which large-scale vaccinations are required. Although the development of vaccines against COVID-19 has contributed greatly to overcoming the pandemic, concerning vaccine side effects from the general public, including medical personnel, and decreased confidence in vaccine efficacy and side effects, present many challenges in promoting and educating vaccinations for new infectious diseases in the future. In addition to plans to develop vaccines for the outbreak of new infectious diseases, education and promotion plans are necessary to administer the latest developments of vaccines to the general public. Moreover, efforts are needed to secure the necessity, legitimacy, and evidence for rapid vaccination on a large scale at the national level. It is also necessary to carefully prepare scientific bases and explanatory statements so that the general public can easily understand them. This study aimed to establish vaccine strategies and vaccination education plans for new infectious diseases that may occur in the future. Many ways to promote vaccination to the general public and healthcare workers should be prepared to ensure that the latest vaccines against new infectious diseases are administered safely. Thus, education and promotion of vaccine efficacy and safety based on specific data from clinical studies are necessary.

show abstract

A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination

Cited by 2 publications

References 126 publications

Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine

Primary Cutaneous Adenoid Cystic Carcinoma in a Rare Location With an Immune Response to a BNT162b2 Vaccine

Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19

Contact Info

Product

Resources

About